LG Life Sciences develops innovative cytoprotective agent

Published: 2009-10-29 06:57:00

Updated: 2009-10-29 06:57:00

LG Life Sciences Ltd. said on October 27 it will carry out the phase 1 clinical study of a drug for the treatment of stroke and myocardial infarction, in collaboration with Asan Medical Center.

The company said it had successfully completed an animal experiment on Cytopro, a novel cytoprotecti...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK